XML 37 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value of Financial Instruments (Tables)
9 Months Ended
Mar. 31, 2013
Fair Value Disclosures [Abstract]  
Short-term Investments and Financial Instruments
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis as of March 31, 2013:

 
Total
 
Quoted
prices in
active
markets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
13,822

 
$
13,822

 
$

 
$

Forward foreign currency exchange contracts
248

 

 
248

 

Total assets at fair value
$
14,070

 
$
13,822

 
$
248

 
$

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
13,822

 
$
13,822

 
$

 
$

Forward foreign currency exchange contracts
200

 

 
200

 

Liability for contingent consideration, current and non-current portion
13,321

 

 

 
13,321

Total liabilities at fair value
$
27,343

 
$
13,822

 
$
200

 
$
13,321



The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2012:

 
Total
 
Quoted
prices in
active
markets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
(in thousands)
Assets:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
11,635

 
$
11,635

 
$

 
$

Forward foreign currency exchange contracts
21

 

 
21

 

Total assets at fair value
$
11,656

 
$
11,635

 
$
21

 
$

Liabilities:
 
 
 
 
 
 
 
Deferred compensation plan investments, current and non-current portion
$
11,635

 
$
11,635

 
$

 
$

Forward foreign currency exchange contracts
110

 

 
110

 

Liability for contingent consideration, current and non-current portion
16,653

 

 

 
16,653

Total liabilities at fair value
$
28,398

 
$
11,635

 
$
110

 
$
16,653

Fair Value, Business Acquisition, Liability for Contingent Consideration
The table below provides a summary of the changes in fair value of the Company’s contingent consideration (Level 3) for the CDC earnout for the quarters and nine months ended March 31, 2013 and 2012:

 
Contingent consideration for the
quarter ended
 
Contingent consideration for the nine months ended
 
March 31,
 
March 31,
 
2013
 
2012
 
2013
 
2012
 
(in thousands)
Fair value at beginning of period
$
13,090

 
$
20,002

 
$
16,653

 
$
23,794

Payments
(61
)
 
(2,000
)
 
(4,777
)
 
(2,000
)
Change in fair value of contingent consideration
100

 
1,072

 
1,396

 
1,244

Foreign currency translation adjustment
192

 
665

 
49

 
(3,299
)
Fair value at end of period
$
13,321

 
$
19,739

 
$
13,321

 
$
19,739